Luderer U, Kavanagh T J, White C C, Faustman E M
Center for Occupational and Environmental Health, University of California, Irvine, USA.
Reprod Toxicol. 2001 Sep-Oct;15(5):495-504. doi: 10.1016/s0890-6238(01)00157-5.
Glutathione (GSH), an antioxidant and conjugator of electrophilic toxicants, prevents toxicant-mediated destruction of ovarian follicles and oocytes. Ovarian GSH has previously been shown to change with estrous cycle stage in rats, suggesting that the gonadotropin hormones may regulate ovarian GSH synthesis. The present studies tested the hypotheses that [1] estrous cycle-related changes in ovarian GSH result from cyclic changes in protein and mRNA expression of the rate-limiting enzyme in GSH synthesis, glutamate cysteine ligase (GCL, also called gamma-glutamylcysteine synthetase), and [2] that these changes result from gonadotropin-mediated regulation of GCL subunit expression. In the first experiment, ovaries were harvested from cycling adult female rats on each stage of the estrous cycle. In the second experiment immature female rats were injected with pregnant mare's serum gonadotropin (PMSG) to stimulate follicular development or with vehicle and killed 8, 24, or 48 h later. In both experiments the ovaries were harvested for [1] total GSH assay, [2] Western analysis for GCL catalytic (GCLc) and regulatory (GCLm) subunit protein levels, or [3] Northern analysis for Gclc and Gclm mRNA levels. Ovarian GSH concentrations and Gclc and Gclm mRNA levels, but not GCL subunit protein levels, varied significantly with estrous cycle stage. PMSG administration significantly increased ovarian GSH concentrations 24 and 48 h later. GCLm protein levels increased significantly at 24 h and 48 h following PMSG. GCLc protein levels did not increase significantly following PMSG. Gcl subunit mRNA levels were not significantly increased at any time point by the planned ANOVA; however, an increase in Gelc at 48 h was identified by t-testing. These results support the hypothesis that gonadotropins regulate ovarian GSH synthesis by modulating GCL subunit expression.
谷胱甘肽(GSH)是一种抗氧化剂和亲电子毒物的结合剂,可防止毒物介导的卵巢卵泡和卵母细胞的破坏。先前已证明大鼠卵巢中的GSH会随发情周期阶段而变化,这表明促性腺激素可能调节卵巢GSH的合成。本研究检验了以下假设:[1]卵巢GSH中与发情周期相关的变化是由GSH合成限速酶谷氨酸半胱氨酸连接酶(GCL,也称为γ-谷氨酰半胱氨酸合成酶)的蛋白质和mRNA表达的周期性变化引起的,以及[2]这些变化是由促性腺激素介导的GCL亚基表达调节引起的。在第一个实验中,从处于发情周期各阶段的成年雌性大鼠中采集卵巢。在第二个实验中,给未成熟雌性大鼠注射孕马血清促性腺激素(PMSG)以刺激卵泡发育,或注射溶剂,并在8、24或48小时后处死。在两个实验中,采集卵巢用于[1]总GSH测定,[2]对GCL催化(GCLc)和调节(GCLm)亚基蛋白水平进行蛋白质印迹分析,或[3]对Gclc和Gclm mRNA水平进行Northern印迹分析。卵巢GSH浓度以及Gclc和Gclm mRNA水平随发情周期阶段有显著变化,但GCL亚基蛋白水平没有变化。注射PMSG后24和48小时,卵巢GSH浓度显著增加。PMSG后24小时和48小时,GCLm蛋白水平显著增加。PMSG后GCLc蛋白水平没有显著增加。通过计划方差分析,在任何时间点Gcl亚基mRNA水平均未显著增加;然而,通过t检验发现在48小时时Gelc有所增加。这些结果支持促性腺激素通过调节GCL亚基表达来调节卵巢GSH合成这一假设。